Nathan Buchbinder appears in Brel Digital’s verified company_founders attribution for Proscia based in United States in the Healthcare sector. This profile records that founder relationship using sources already on file for the company. Personal biography details that are not evidenced in those sources are omitted.
Company context (from the verified Proscia profile): Philadelphia digital pathology platform company embedding AI-native intelligence in Concentriq for labs and life sciences
Why the company matters (verified company field): Proscia argues pathology AI should be woven into the platform layer — not bolted onto legacy digital slide viewers — and its Fifth Generation Concentriq launch is a concrete 2026 product bet that enterprise pathology software becomes the intelligence substrate for precision medicine.
Official company website on file: https://proscia.com. Readers should consult that site and the Sources section for primary evidence.
Brel Digital does not invent prior roles, education, funding history, or awards for founder profiles. Where additional verified public leadership pages become available, this profile should be deepened in a subsequent editorial review.